메뉴 건너뛰기




Volumn 92, Issue 11, 2007, Pages 1581-1582

The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: A matched-pair analysis from the ALL-BFM study group

Author keywords

Acute lymphoblastic leukemia; Childhood; NQO1; Polymorphism; Secondary malignant neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

EID: 36348976416     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10260     Document Type: Article
Times cited : (18)

References (10)
  • 1
    • 0343183162 scopus 로고    scopus 로고
    • Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: Significantly lower risk without cranial radiotherapy
    • Löning L, Zimmermann M, Reiter A, Kaatsch P, Henze G, Riehm H, et al. Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 2000;95:2770-5.
    • (2000) Blood , vol.95 , pp. 2770-2775
    • Löning, L.1    Zimmermann, M.2    Reiter, A.3    Kaatsch, P.4    Henze, G.5    Riehm, H.6
  • 2
    • 0037097806 scopus 로고    scopus 로고
    • Low incidence of secondneoplasms among children diagnosed with acute lymphoblastic leukemia after 1983
    • Bhatia S, Sather HN, Pabustan OB, Trigg ME, Gaynon PS, Robison LL. Low incidence of secondneoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 2002;99:4257-64.
    • (2002) Blood , vol.99 , pp. 4257-4264
    • Bhatia, S.1    Sather, H.N.2    Pabustan, O.B.3    Trigg, M.E.4    Gaynon, P.S.5    Robison, L.L.6
  • 3
    • 0041623001 scopus 로고    scopus 로고
    • Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia
    • Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 2003;349:640-9.
    • (2003) N Engl J Med , vol.349 , pp. 640-649
    • Pui, C.H.1    Cheng, C.2    Leung, W.3    Rai, S.N.4    Rivera, G.K.5    Sandlund, J.T.6
  • 4
    • 0036518402 scopus 로고    scopus 로고
    • NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: A HuGE review
    • Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 2002;4:62-70.
    • (2002) Genet Med , vol.4 , pp. 62-70
    • Nebert, D.W.1    Roe, A.L.2    Vandale, S.E.3    Bingham, E.4    Oakley, G.G.5
  • 5
    • 0034517924 scopus 로고    scopus 로고
    • Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster
    • Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G, et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia 2000;14:2205-22.
    • (2000) Leukemia , vol.14 , pp. 2205-2222
    • Schrappe, M.1    Reiter, A.2    Zimmermann, M.3    Harbott, J.4    Ludwig, W.D.5    Henze, G.6
  • 6
    • 0033564977 scopus 로고    scopus 로고
    • Prevalence of the inactivating 609C - >T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia
    • Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, et al. Prevalence of the inactivating 609C - >T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999;94:803-7.
    • (1999) Blood , vol.94 , pp. 803-807
    • Larson, R.A.1    Wang, Y.2    Banerjee, M.3    Wiemels, J.4    Hartford, C.5    Le Beau, M.M.6
  • 7
    • 0033755155 scopus 로고    scopus 로고
    • Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia
    • Naoe T, Takeyama K, Yokozawa T, Kiyoi H, Seto M, Uike N, et al. Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 2000; 6:4091-5.
    • (2000) Clin Cancer Res , vol.6 , pp. 4091-4095
    • Naoe, T.1    Takeyama, K.2    Yokozawa, T.3    Kiyoi, H.4    Seto, M.5    Uike, N.6
  • 8
    • 12244252803 scopus 로고    scopus 로고
    • Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies
    • Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, Amylon MD, et al. Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. Pharmacogenetics 2002;12: 605-11.
    • (2002) Pharmacogenetics , vol.12 , pp. 605-611
    • Blanco, J.G.1    Edick, M.J.2    Hancock, M.L.3    Winick, N.J.4    Dervieux, T.5    Amylon, M.D.6
  • 9
    • 27844502518 scopus 로고    scopus 로고
    • The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan
    • Eguchi-Ishimae M, Eguchi M, Ishii E, Knight D, Sadakane Y, Isoyama K, et al. The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan. Haematologica 2005;90:1511-5.
    • (2005) Haematologica , vol.90 , pp. 1511-1515
    • Eguchi-Ishimae, M.1    Eguchi, M.2    Ishii, E.3    Knight, D.4    Sadakane, Y.5    Isoyama, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.